Investigating antimicrobial resistance determinants and micropollutants in urban sewage treatment plants of India: Occurrence, removal and ecotoxicological risk

Abstract

Environmental contamination caused by emerging pollutants (EPs) and their associated ecological risk have received limited attention in India. Thus, this study aims to address this gap by investigating the occurrence and removal of antibiotic resistant bacteria (ARB), antibiotic resistance genes (ARGs) and pharmaceutical and personal care products (PPCPs) in two sewage treatment plants (STPs) in New Delhi. The study also assessed the ecological risk associated with PPCPs in aquatic environments. Among the targeted ARB and ARGs, erythromycin resistant bacteria and ermB gene, respectively were the most ubiquitous pollutants in the influent of both STPs. In the final effluent, there was a reduction ranging from 0.8 log to 2.8 log units for most ARB, while removal of the majority of ARGs was less than 1 log unit. The secondary treatment demonstrated better removal of total ARG concentrations compared to the tertiary treatment methods employed in both STPs. Regarding PPCPs, metformin was quantified in both influent and effluent samples at a concentration exceeding 19,000 ng/L, indicating its persistence in wastewater. High concentrations of ARB, ARGs, and PPCPs were observed in undigested biosolids, while low to moderate removal of these pollutants was observed after anaerobic digestion. To assess the ecological risk, a risk quotient (RQ) assessment was conducted. The results revealed that compounds such as erythromycin, terbinafine, 17-α ethinylestradiol (EE2), 17-β estradiol (E2), diclofenac, triclosan, carbamazepine, and mefenamic acid exhibited high risks in the effluent. Additionally, EE2 and E2 showed higher risk levels in the digested biosolids, indicating potential risks to the aquatic ecosystem.